Mechanical ventilation of patients suffering from acute respiratory distress syndrome (ARDS) may contribute to further lung injury ([@R1]). Modern ventilation management aims to avoid this by limiting tidal volume (V~T~) and end-inspiratory pressure ([@R2]--[@R4])---where both are not independent, but rather conjoined via the respiratory system compliance. However, these lung-protective ventilation strategies are limited by the requirement to provide sufficient oxygenation and carbon dioxide clearance. Additionally, lung recruitment maneuvers and higher positive end-expiratory pressure (PEEP) support recruitment of lung tissue, but their role for lung-protective ventilation is currently under heavy debate ([@R5]--[@R7]).

Recently, we proposed ventilation with a constant expiratory flow as a new possibility to recruit lung tissue. In healthy pigs, we could demonstrate that a diminished expiratory derecruitment can be achieved with a constant expiratory flow and this was associated with an elevated Pa[o]{.smallcaps}~2~ while compared with ventilation with conventional passive expiration with the same PEEP, peak inspiratory pressure, and V~T~ ([@R8]). Furthermore, we could demonstrate an attenuation of lung injury by an almost constant expiratory flow in an animal model of ARDS. By controlling the expiratory flow, a significant reduction of PEEP and the end-inspiratory plateau pressure was possible while maintaining comparable Pa[o]{.smallcaps}~2~ ([@R9]). However, whether the demonstrated attenuation of lung injury was caused by the reduced pressures or the constant expiratory flow remained unclear.

So far, only little attention has been paid to the expiratory flow and its potential role for lung-protective ventilation. One reason might be that standard ventilators do not control the expiratory flow. To our knowledge, there is only one new type of ventilator (Evone; Ventinova Medical B.V., Eindhoven, The Netherlands) that uses a constant inspiratory and expiratory flow. This ventilation mode was termed (bidirectional) "flow-controlled ventilation" (FCV) by the manufacturer. First clinical use for intraoperative ventilation was reported recently ([@R10]), but its use was not described in the setting of ARDS so far.

Taken together, our previous results suggest potential lung-protective properties of a constant expiratory flow beyond the limitation of V~T~ and end-inspiratory pressure and led us to hypothesize that FCV attenuates lung injury during mechanical ventilation. In the work described below, we, therefore, compared FCV with volume-controlled ventilation (VCV) in terms of gas exchange, lung injury markers, lung aeration, and ventilation variables in a porcine model of oleic acid-induced ARDS.

METHODS
=======

The study was approved by the appropriate governmental body (Regierungspräsidium Freiburg, file reference G-16/77) and conducted in accordance with the European law on the protection of animals used for scientific purposes (EU-Directive 2010/63).

A detailed description of the applied methods can be found in an **online data supplement** (Supplemental Digital Content 1, <http://links.lww.com/CCM/F220>). Briefly, 19 German landrace hybrid pigs (anesthetized, endotracheally intubated, ventilated, and fully instrumented, in the supine position) were subjected to oleic acid-induced lung injury (**Fig. [1](#F1){ref-type="fig"}**). All animals were initially ventilated with VCV using a standard ICU ventilator (Evita 4; Dräger medical, Lübeck, Germany) with F[io]{.smallcaps}~2~ of 0.8, V~T~ of 7 mL/kg body weight, PEEP of 9 cm H~2~O, and inspiratory to expiratory ratio of 1:1.2. The respiratory rate (RR) was adjusted to maintain the arterial blood pH above 7.2. The oleic acid was individually titrated until the Pa[o]{.smallcaps}~2~-F[io]{.smallcaps}~2~ ratio remained stable between 100 and 150 torr (13.3 and 20 kPa) for 20 minutes under constant ventilation.

![Timeline of experimental protocol. FCV = flow-controlled ventilation, VCV = volume-controlled ventilation.](ccm-48-e241-g001){#F1}

The random allocation to either VCV (control) or FCV was disclosed, and the endotracheal tube was disconnected from the ventilator for 30 seconds and pulmonary edema fluid removed via active tracheal suction (all animals). The animals of the control group were reconnected to the standard ventilator and the animals of the FCV group were connected to a prototype ventilator capable of providing FCV (Evone; Ventinova Medical B.V., Eindhoven, The Netherlands). Ventilation was started with identical settings as mentioned above for both groups and maintained for 3 hours. A dynamic CT scan (60 axial images in 45 s on the same thoracic level) was then taken under the designated ventilation mode, and samples of lung tissue and bronchoalveolar lavage (BAL) fluid were collected.

The primary endpoint was the Pa[o]{.smallcaps}~2~. Secondary endpoints included Pa[co]{.smallcaps}~2~, tracheal pressure (P~trach~), V~T~, minute volume, RR, and dynamic compliance of the respiratory system. Recorded hemodynamic parameters were heart rate, mean arterial pressure, mean pulmonary arterial pressure, cardiac index, and the extravascular lung water index (ELWI). Each of these parameters was determined every 30 minutes. The CT scan data were analyzed separately for dependent and independent lung regions and divided into four compartments according to Gattinoni et al ([@R11]): 1) overinflated lung tissue; 2) normally aerated; 3) poorly aerated; and 4) nonaerated lung tissue. Lung tissue samples were hematoxylin and eosin stained for determination of alveolar wall thickness and cell infiltration. Concentrations of total protein (TP~BAL~) and surfactant protein A (SP-A~BAL~) were determined from the BAL fluid. Both protein measurements were normalized to the value of the control group.

An a priori sample size calculation based on the assumption of an effect size of 1.5 [sd]{.smallcaps}s in the primary endpoint, an intended power of 80%, an α error of 5%, and an equal sample ratio resulted in *n* equals to 7 for each group. Data and statistical analyses were done offline with MATLAB (R2017b; MathWorks, Natick, MA). A linear mixed-effects model ([@R12]) was applied to the measurements, with the group allocation as a fixed effect and a random intercept by-subject. For repeated measurements, a random intercept by-time was added to the model. Statistical significance (*p* \< 0.05) between the two groups was determined via a likelihood ratio test comparing the full model with a model reduced by the fixed effect. The goodness of fit of the applied linear mixed-effects model was assessed by visual inspection of the plotted residuals and by calculating adjusted *R*^2^ values (**Supplemental Digital Content 2**, <http://links.lww.com/CCM/F220>). Additionally, the [se]{.smallcaps} given for the estimate allows for assessment of the uncertainty of the modeled mean. For consistency and comparability, all data are reported as mean ± [sem]{.smallcaps}, if not declared otherwise.

RESULTS
=======

In total, 19 animals were included in the study to obtain 14 evaluable datasets, seven in each group. Two animals were excluded before the randomized group allocation was disclosed due to insufficient oxygenation under baseline conditions (Pa[o]{.smallcaps}~2~-F[io]{.smallcaps}~2~ ratio, 85 torr \[11.3 kPa\] and 79 torr \[10.5 kPa\], respectively). In the FCV group, three animals were excluded due to software malfunction of the ventilator prototype (*n* = 2) and malignant arrhythmia (*n* = 1). Data for body weight, medication, and IV fluid substitution are provided as **Supplemental Digital Content 3** (<http://links.lww.com/CCM/F220>). Data for the excluded animals can be found as **Supplemental Digital Content 4 and 5** (<http://links.lww.com/CCM/F220>).

Ventilation and hemodynamic results are summarized for both groups in **Figure [2](#F2){ref-type="fig"}** and **Table [1](#T1){ref-type="table"}**. With FCV, Pa[o]{.smallcaps}~2~ was higher (effect size, 49 torr \[6.5 kPa\]; 95% CI, 7--90 torr \[0.9--12.0 kPa\]) compared with the control group. Comparable Pa[co]{.smallcaps}~2~ levels were achieved with a lower minute volume in the FCV group compared with the control (effect size, −2.4 L/min; 95% CI, −3.4 to −1.3 L/min), which was effected by a lower RR in the FCV group (effect size, −3/min; 95% CI, −5 to −1/min). The tracheal inspiratory plateau pressure (plateau P~trach~) and driving pressure (ΔP~trach~) were comparable in both groups. Mean P~trach~ (P~trach~ mean) was higher in the FCV group (effect size, 1.4 cm H~2~O; 95% CI, 0.13--2.6 cm H~2~O). All hemodynamic variables were comparable in both groups.

###### 

Summary of Respiratory, Hemodynamic, and Lung Injury Markers

![](ccm-48-e241-g002)

![Measured (baseline \[BL\], T30--T180) and calculated (LMEM) variables for gas exchange and respiratory parameters. **A**, Pa[o]{.smallcaps}~2~. **B**, Pa[co]{.smallcaps}~2~. **C**, Tracheal plateau pressure (P~plat~) and tracheal mean pressure (P~mean~). **D**, Minute volume (MV). During BL, both groups were ventilated with a volume-controlled mode. FCV = flow-controlled ventilation, LMEM = calculated data from the linear mixed-effects model, P~trach~ = tracheal pressure.](ccm-48-e241-g003){#F2}

The lung tissue samples showed thinner alveolar walls (effect size, −2.3 µm; 95% CI, −2.7 to −1.8 µm) and a lower cell infiltration rate (effect size, −12 *n*/field; 95% CI, −16 to −7 *n*/field) after FCV compared with the control group (Table [1](#T1){ref-type="table"}). Representative stained lung tissue samples can be found as **Supplemental Digital Content 9** (<http://links.lww.com/CCM/F224>; legend, <http://links.lww.com/CCM/F220>). The concentration of TP~BAL~ was comparable in both groups but was accompanied by a higher concentration of SP-A~BAL~ after FCV (effect size, 0.10 \[normalized\]; 95% CI, 0.003--0.196).

###### 

Percentages of Four Lung Compartments of Independent and Dependent Lung Areas for Flow-Controlled Ventilation and Control Group

![](ccm-48-e241-g004)

The dynamic CT scans revealed a left shifted histogram of CT density during FCV in the dependent lung areas (**Fig. [3](#F3){ref-type="fig"}**). Further analysis showed an increased percentage of normally aerated lung tissue (effect size, 13%; 95% CI, 5--21%) and a decreased percentage of nonaerated lung tissue (effect size, −15%; 95% CI, −28% to −1%) during FCV in the dependent lung areas compared with the control group (**Table 2**). Representative sequences of the dynamic CT scans are provided as additional movie files (**Supplemental Digital Content 6**, <http://links.lww.com/CCM/F221>; and **Supplemental Digital Content 7**, <http://links.lww.com/CCM/F222>---and **legend**, <http://links.lww.com/CCM/F220>).

![Histograms of CT densities for dependent (**A**) and independent (**B**) lung area in steps of 50 Hounsfield units (HU). Indicated are four distinctive lung compartments: 1) overinflated, 2) normally aerated, 3) poorly aerated, and 4) nonaerated lung tissue. FCV = flow-controlled ventilation.](ccm-48-e241-g005){#F3}

DISCUSSION
==========

The objective of this preclinical randomized study was to compare the effects of FCV with conventional mechanical ventilation in an ARDS model using pigs. The main findings are that, compared with VCV, with FCV, 1) the gas exchange was improved in terms of improved arterial oxygenation and lower minute volume required to achieve comparable Pa[co]{.smallcaps}~2~, 2) the amount of aerated tissue in the dependent lung regions was higher, and 3) alveolar wall thickness and cell infiltration rate were lower, and the concentration of surfactant protein A in BAL fluid was higher.

Current lung-protective ventilation strategies for the treatment of ARDS focus mainly on limiting of V~T~ and inspiratory pressure while still providing sufficient arterial oxygenation ([@R13], [@R14]). High V~T~ and high inspiratory pressure support high Pa[o]{.smallcaps}~2~ ([@R15]) but also increase the risk for ventilator-induced lung injury ([@R16]) and increase mortality ([@R17]). In this study, we found that by using FCV, we could improve gas exchange and attenuate lung injury compared with VCV---with comparable V~T~, PEEP, plateau pressure, and driving pressure. This suggests a potential therapeutic option for patients with ARDS which goes beyond V~T~ and pressure limitation.

The main difference between the two ventilation modes we used is the expiratory flow profile with time (**Supplemental Digital Content 8**, <http://links.lww.com/CCM/F223>; and legend, <http://links.lww.com/CCM/F220>). The expiratory flow rate is constant and comparatively low during FCV, whereas during conventional, noncontrolled expiration, a high initial peak flow is followed by the well-known exponential decline. In accordance with a recent suggestion ([@R18]), we suspect this as the most influential mechanism on the obtained results.

Recruitment of Lung Tissue for Gas Exchange
-------------------------------------------

The constant expiratory flow of FCV implies two possible mechanisms that lead to the observed improvements in gas exchange: First, mean P~trach~ is elevated and consequently Pa[o]{.smallcaps}~2~ rises ([@R19]). However, the time course of these two variables indicate an additional effect. Although mean P~trach~ was higher at T30 and then drifted around the same level, oxygenation improved further. Hence, the second possible mechanism is the constant lung deflation, which has been shown to maintain oxygenation with significant lower levels of PEEP and to attenuate lung injury in a pig model with oleic acid-induced ARDS ([@R9]). In lung healthy pigs, FCV improved lung recruitment and oxygenation ([@R8]). The controlled deflation lengthens the time the alveoli are subjected to a pressure that exceeds closing pressure and the time until opening pressure is applied with the next inspiration is reduced. This recruiting effect can be seen in the dynamic CT scans in our study, which show a shift from nonaerated tissue to normally aerated tissue in the dependent lung regions.

One could argue that it may be possible to gain the desired effects by a simple increase of PEEP. However, increasing PEEP may increase overinflation in the independent lung regions ([@R20], [@R21]). This mechanism was suspected as a contributor to a higher mortality in ARDS patients treated with higher levels of PEEP in a recently published study ([@R7]). In our study, CT analyses did not indicate a relevant amount of overinflated lung tissue, in either ventilation mode. At this point it must be stressed, that the recruiting effect in this study was achieved without affecting PEEP and without recruitment maneuvers. Both were recently attributed to a higher mortality in ARDS patients in the aforementioned study ([@R7]).

The left shift in the histogram and the reduction of nonaerated lung tissue indicates a more homogenous ventilation in the dependent lung regions during FCV. This is supported by two investigations of ventilation with a controlled expiratory lung deflation which demonstrated a more homogeneous ventilation distribution using electrical impedance tomography in lung healthy patients ([@R22]) and in pigs with an oleic acid-induced ARDS ([@R23]).

We suspect that the steady deflation is a powerful mechanism that contributes substantially to the homogeneity of ventilation. Recently, Katira et al ([@R24]) showed that an abrupt deflation after sustained inflation causes lung injury. Of course, the setting of this study was different to ours and the comparison of results should be treated with caution. However, in presence of ARDS, compliance is substantially decreased and the lungs empty within a few hundred milliseconds. Consequently, abrupt deflation from end-inspiratory pressure to PEEP occurs in every conventional expiratory cycle. Additionally, the ARDS lung tissue inhomogeneity---with fast and slow emptying lung areas, which are characterized by different expiratory time constants---correlates with the severity of lung injury ([@R25]). Controlled expiration offers lung deflation independent of time constants and may contribute by this mechanism to an improved lung homogeneity. In consequence, improved lung homogeneity may attenuate lung injury as indicated in our study by alveolar wall thickness, cell infiltration rate, and SP-A~BAL~. The concentration of SP-A in BAL fluid from ARDS patients has been found to be lower than that in healthy volunteers ([@R26]) and correlates inversely to the severity of lung injury in polytraumatized patients ([@R27]). It was proposed as a key player for maintaining the integrity of the alveolar epithelium ([@R28]) by exerting antiapoptotic effects on pulmonary epithelial cells ([@R29]) and by modulating the response of inflammatory cells ([@R30]). Hence, the higher concentration of SP-A we found after FCV might have contributed to the thinner alveolar walls and the lower cell infiltration.

In summary, we propose that a constant lung deflation recruits lung tissue by improving lung tissue homogeneity without potential harmful side effects as higher minimal or maximal pressures of the respiratory system. The improved lung tissue homogeneity consequently attenuates lung injury.

Assessment of Lung Injury
-------------------------

We assessed the level of lung injury according to the recommendations of the American Thoracic Society ([@R31]), based on measurements in four different areas: 1) physiologic dysfunction, assessed by Pa[o]{.smallcaps}~2~, Pa[co]{.smallcaps}~2~, and corresponding minute volume, measured every 30 minutes; 2) histologic assessment of alveolar wall thickness; 3) evaluation of the integrity of the alveolar capillary barrier via concentration of total protein in BAL fluid as well as determination of ELWI; and 4) measurement of the inflammatory response via count of tissue infiltrated cells in stained lung tissue. Our results showed that lung injury was attenuated after FCV in three of these areas. Only the results for ELWI and TP~BAL~ concentrations were inconclusive. However, a recent study showed a correlation between faster resolution of lung injury and higher TP~BAL~ concentrations at an early stage of ARDS in ICU patients ([@R32]). In summary, we feel confident that our results provide evidence for an attenuated lung injury after FCV.

Limitations
-----------

The design and the experimental protocol for this study entail certain limitations. They were chosen to enable stable ventilation with fixed ventilator settings to examine the underlying mechanisms of the suspected lung-protective properties of a controlled expiration. However, we chose to adapt the RR continuously to the measured carbon dioxide partial pressure and the recruiting effects of FCV enabled ventilation with a lower minute volume by reducing the RR. However, ventilation of isolated rabbit lungs with a lower RR was attributed with an attenuation of lung injury ([@R33]) and hence, the reduced RR may have contributed to the observed results. However, the effect of the RR on outcome in ARDS patients was not studied yet. Although the conception of attenuation of lung injury due to a reduced cyclic opening and collapse of alveoli is widely accepted, an actual recommendation for ventilation of ARDS lungs merely state that a "balanced \[RR\] of 20--30/min" should be applied ([@R34]). However, adjusting the RR to the Pa[co]{.smallcaps}~2~ and the pH, respectively, mirrors the actual recommendations of the ARDS Network. Additionally, the pH has a direct effect on the oxygen-binding affinity of hemoglobin (known as "Bohr effect"), hence a variation in Pa[co]{.smallcaps}~2~ and consequently in the pH would have affected the primary endpoint. In summary, our experimental approach to adjust the RR to the pH reflected not only current clinical recommendations but also protected the primary endpoint from a potential influence in addition to the actual intervention.

FCV resulted in a higher mean P~trach~, which may have contributed to the higher Pa[o]{.smallcaps}~2~, as noted above. Additionally, a previous study where a virtually constant expiratory flow was compared with a conventional expiration with comparable mean airway pressure (and a comparable RR) could demonstrate an attenuation of lung injury in a porcine model of ARDS ([@R9]). Regarding these previous results, it seems justified to propose the controlled expiration as the underlying cause for the demonstrated benefits. However, regarding exclusively the data of the presented study, we cannot exclude an influence of the lower RR and the higher mean P~trach~ on the observed results.

We propose that the beneficial effects of a constant lung deflation are due to a recruiting effect which improves lung homogeneity. Obviously, the demonstrated effect size is depending on the amount of recruitable lung tissue and other settings (e.g., prone positioning) may result in different effect sizes.

Both groups were ventilated with comparable V~T~. However, it is worth noting that in our study the lungs received a volume load toward the upper end of the recommended range (4--8 mL/kg) ([@R13]). Having said that, we note that the mean V~T~ in a recent large observational study in ARDS patients was 7.5 mL/kg predicted body weight ([@R35]). We, therefore, feel that our results mirror usual clinical practice and further suggest that FCV might achieve a comparable level of oxygenation with lower V~T~ and/or lower inspiratory pressure.

The observational time of 3 hours was chosen to assess the short-term effects of two different ventilation modes. Although it was long enough to gain insights into the suspected underlying mechanisms, studies with longer observational periods are needed to evaluate long-term effects of FCV.

Our dynamic CT scans were recorded on one thoracic level and may not represent the whole lung. Our aim was to evaluate intratidal changes of the respective ventilation mode rather than to generate static images of end-inspiratory and end-expiratory intrathoracic gas volume. Additionally, the relevance of a dynamic CT scan was not addressed yet in a clinical setting. Regarding the considerable exposition to radiographs, a study in humans seems unfeasible in the near future.

We used two different ventilators, each with its own pressure and flow measuring system which poses a technical limitation of the study. Additionally, for the control group, P~trach~ was continuously calculated from airway pressure and flow as described previously ([@R36]). However, there is no difference of airway and P~trach~ for inspiratory plateau pressure and PEEP, as long as flow is absent. The difference of the calculated mean pressure is almost negligible for continuously recorded data, since airway pressure is higher during inspiration but is lower during expiration, compared with P~trach~. According to these considerations, we are confident that we report consistent data for P~trach~ for both groups.

It is also worth considering the potential impact of FCV on the hemodynamics, reasoned by the elevated mean P~trach~ which creates an elevated intrathoracic pressure and thus may impair venous return to the heart ([@R37]). However, we found a difference of only 2 cm H~2~O in mean P~trach~ and no effects on hemodynamic variables; therefore, we estimate the effects on hemodynamics as marginal.

The translation of these results to the treatment of ARDS patients should be handled with care. FCV currently is depending on a Tritube (Ventinova Medical B.V., Eindhoven, The Netherlands), which does not allow for assisted spontaneous breathing and may affect patient-ventilator asynchrony. Additionally, if FCV still yields lung-protective properties with an individualized ventilator therapy (e.g., as proposed by the ARDS network) remains to be elucidated.

CONCLUSIONS
===========

This study indicates lung-protective properties of a controlled expiration beyond V~T~ and inspiratory pressure limitation in an animal model of ARDS. Further investigations of a controlled expiration and its therapeutic potential for the treatment of ARDS are necessary.
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